Aprea Therapeutics, Inc. (APRE) Net Income by Year
Aprea Therapeutics, Inc. reported a net loss of $12.6M in fiscal year 2025. This represents an increase of 2.8% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Aprea Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
APRE Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
APRE Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Aprea Therapeutics, Inc. financials
Frequently Asked Questions
What was Aprea Therapeutics, Inc.'s net income in fiscal year 2025?
Aprea Therapeutics, Inc. reported a net loss of $12.6M in fiscal year 2025.
How fast is Aprea Therapeutics, Inc.'s net income growing?
Aprea Therapeutics, Inc. (APRE) net income rose by 2.8% year over year, from -$13.0M to -$12.6M in fiscal year 2025.
How has Aprea Therapeutics, Inc.'s net income changed over the years?
Across the 9 fiscal years this page covers, Aprea Therapeutics, Inc. (APRE) net income went from -$15.2M in fiscal year 2017 to -$12.6M in fiscal year 2025.
What was Aprea Therapeutics, Inc.'s net income in the most recent quarter?
Aprea Therapeutics, Inc. (APRE) reported -$3.6M in net income in Q2 2026. This represents a decrease of 10.9% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Aprea Therapeutics, Inc. (APRE) reported on that line in every period on record.